Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26,491 INR | -0.19% | +3.63% | +15.93% |
10/05 | Abbott India's Net Profit Climbs in Fiscal Q4; Shares Up 3% | MT |
09/05 | Drugmaker Abbott India posts Q4 profit rise on higher sales | RE |
Sales 2024 | 58.49B 702M | Sales 2025 * | 64.7B 777M | Capitalization | 563B 6.76B |
---|---|---|---|---|---|
Net income 2024 | 12.01B 144M | Net income 2025 * | 13.12B 158M | EV / Sales 2024 | 9.79 x |
Net cash position 2024 * | 22.66B 272M | Net cash position 2025 * | 21.47B 258M | EV / Sales 2025 * | 8.37 x |
P/E ratio 2024 |
47.7
x | P/E ratio 2025 * |
42.9
x | Employees | 3,700 |
Yield 2024 * |
1.11% | Yield 2025 * |
1.35% | Free-Float | 24.52% |
1 day | -0.19% | ||
1 week | +3.63% | ||
Current month | +0.17% | ||
1 month | +1.33% | ||
3 months | -10.32% | ||
6 months | +13.73% | ||
Current year | +15.93% |
Managers | Title | Age | Since |
---|---|---|---|
Swati Dalal
CEO | Chief Executive Officer | - | 01/95/01 |
Director of Finance/CFO | - | - | |
Jejoe Karankumar
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 01/19/01 | |
Chairman | 81 | 01/68/01 | |
Director/Board Member | 67 | 01/96/01 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 26,491 | -0.19% | 5,257 |
16/24/16 | 26,543 | +0.50% | 10,430 |
15/24/15 | 26,411 | -1.37% | 6,434 |
14/24/14 | 26,778 | -1.11% | 8,340 |
13/24/13 | 27,080 | +2.69% | 17,401 |
Delayed Quote NSE India S.E., May 17, 2024 at 05:13 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- ABBOTINDIA Stock
- ABBOTINDIA Stock